| Penile Squamous Cell Carcinoma studied in …STUDIED_INderived10 of 29show all (up to 200) |
|---|
| → studied in | NCT07217171Phase 1 · recruiting A Study Evaluating the Safety, Efficacy, and Pharmacokinetics (PK) of EVOLVE104 in Participants With Advanced Urothelial and Squamous Cell Carcinomas · condition mapped CURATED_BROADER · 29 trials mapped (17 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03074513Phase 2 · active not recruiting Atezolizumab and Bevacizumab in Treating Patients With Rare Solid Tumors · condition mapped ALIAS · 29 trials mapped (17 active) | — | — | Human Papillomavirus-Related Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07808359Phase 2 · not yet recruiting Amivantamab in Patients With Metastatic/Recurrent Penile Squamous Cell Carcinoma · condition mapped CURATED_BROADER · 29 trials mapped (17 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07815197Phase 2 · not yet recruiting Sacituzumab Tirumotecan as Second-Line Treatment for Penile Cancer · condition mapped CURATED_BROADER · 29 trials mapped (17 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02496208Phase 1 · active not recruiting Cabozantinib S-malate and Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic Genitourinary Tumors · condition mapped CURATED_BROADER · 29 trials mapped (17 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02305654Phase 3 · active not recruiting International Penile Advanced Cancer Trial (International Rare Cancers Initiative Study) · condition mapped ALIAS · 29 trials mapped (17 active) | — | — | Penile Squamous Cell Carcinoma, Usual Type | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07767266Phase 2 · not yet recruiting Neoadjuvant Pucotenlimab and Becotatug Vedotin for Locally Advanced Penile Cancer · condition mapped CURATED_BROADER · 29 trials mapped (17 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06161532Phase 2 · recruiting Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C... · condition mapped ALIAS · 29 trials mapped (17 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07110038Phase 2 · recruiting DEPECA-1 - A Phase II Study to Evaluate a First-line Systemic Therapy With Enfortumab Vedotin Plus Avelumab for Advanced and Metastatic Penile Carcinoma · condition mapped CURATED_BROADER · 29 trials mapped (17 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02834013Phase 2 · active not recruiting Nivolumab and Ipilimumab in Treating Patients With Rare Tumors · condition mapped CURATED_BROADER · 29 trials mapped (17 active) | — | — | Penile Squamous Cell Carcinoma | 1 | Observed | clinicaltrials | graph → |